China's government officials have called for a boost to the biotech capacity and the introduction of a novel food framework ...

Olverembatinib (HQP1351), a novel, next-generation TKI and the first third-generation BCR-ABL1 TKI, has been approved in ...

As global markets grapple with fluctuating economic indicators and policy uncertainties, Asian tech stocks have shown resilience amid mixed performances across major indices. In this context, ...

Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2024 and highlighted recent business progress.

The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...

AccurEdit Therapeutics today announced that its innovative in vivo gene editing product, ART001, has obtained Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA).

The 2025 Suzhou Shushan Pear Blossom Festival market kicked off in Shushan village, Suzhou High-tech Zone of Jiangsu province ...

A new graphic cookbook — complete with recipes and comic book-style illustrations — tells the backstories of the names behind ...

Here are the latest restaurants, shops and exhibitions to visit in Shanghai during Shanghai Fashion Week's fall 2025 edition.

A 10-time LPGA Tour champion in the United States, Feng found success in Japan as well, securing seven JLPGA titles during ...

China's unwavering commitment to opening-up will propel new industrialization, green growth and digital transformation, ...

A Chinese street food malatang outlet, YangGuoFu Malatang in Suzhou, East China's Jiangsu Province, was ordered to shut down ...